These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19358940)

  • 21. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.
    Montalescot G; Wiviott SD; Braunwald E; Murphy SA; Gibson CM; McCabe CH; Antman EM;
    Lancet; 2009 Feb; 373(9665):723-31. PubMed ID: 19249633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study).
    Pinto DS; Kirtane AJ; Pride YB; Murphy SA; Sabatine MS; Cannon CP; Gibson CM;
    Am J Cardiol; 2008 Feb; 101(3):303-7. PubMed ID: 18237589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clopidogrel bisulfate: in ST-segment elevation myocardial infarction.
    Dickie JS; Scott LJ
    Am J Cardiovasc Drugs; 2006; 6(6):407-14. PubMed ID: 17192131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy.
    Leé S; Vargová K; Hizoh I; Horváth Z; Gulácsi-Bárdos P; Sztupinszki Z; Apró A; Kovács A; Préda I; Tóth-Zsámboki E; Kiss RG
    Thromb Res; 2014 Feb; 133(2):257-64. PubMed ID: 24359966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis of short-term clopidogrel therapy for ST elevation myocardial infarction.
    Gibler KB; Huskamp HA; Sabatine MS; Murphy SA; Cohen DJ; Cannon CP
    Crit Pathw Cardiol; 2010 Mar; 9(1):14-8. PubMed ID: 20215905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: an analysis from the TRITON-TIMI 38 trial.
    De Servi S; Goedicke J; Schirmer A; Widimsky P
    Eur Heart J Acute Cardiovasc Care; 2014 Dec; 3(4):363-72. PubMed ID: 24818952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
    J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes in patients with ST-segment elevation acute myocardial infarction treated with clopidogrel versus prasugrel (from the INFUSE-AMI trial).
    Brener SJ; Oldroyd KG; Maehara A; El-Omar M; Witzenbichler B; Xu K; Mehran R; Gibson CM; Stone GW
    Am J Cardiol; 2014 May; 113(9):1457-60. PubMed ID: 24630789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clopidogrel in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention.
    Hamdalla H; Moliterno DJ
    Expert Opin Pharmacother; 2006 Aug; 7(12):1669-73. PubMed ID: 16872270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of clopidogrel in abolishing the increased risk of reinfarction associated with higher platelet counts in patients with ST-elevation myocardial infarction (results from CLARITY-TIMI 28).
    Gibson CM; Ly HQ; Murphy SA; Ciaglo LN; Southard MC; Stein EB; Buros JL; Sabatine MS; Cannon CP;
    Am J Cardiol; 2006 Sep; 98(6):761-3. PubMed ID: 16950180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes According to Cardiac Catheterization Referral and Clopidogrel Use Among Medicare Patients With Non-ST-Segment Elevation Myocardial Infarction Discharged Without In-hospital Revascularization.
    Hess CN; Hellkamp AS; Roe MT; Thomas L; Scirica BM; Peng SA; Peterson ED; Wang TY
    J Am Heart Assoc; 2016 Mar; 5(3):e002784. PubMed ID: 26976877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unfractionated heparin-clopidogrel combination in ST-elevation myocardial infarction not receiving reperfusion therapy.
    Bugiardini R; Dorobantu M; Vasiljevic Z; Kedev S; Knežević B; Miličić D; Calmac L; Trninic D; Daullxhiu I; Cenko E; Ricci B; Puddu PE; Manfrini O; Koller A; Badimon L;
    Atherosclerosis; 2015 Jul; 241(1):151-6. PubMed ID: 25988359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefits and risks of clopidogrel pretreatment before coronary artery bypass grafting in patients with ST-elevation myocardial infarction treated with fibrinolytics in CLARITY-TIMI 28.
    McLean DS; Sabatine MS; Guo W; McCabe CH; Cannon CP
    J Thromb Thrombolysis; 2007 Oct; 24(2):85-91. PubMed ID: 17323134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy.
    Gurbel PA; Erlinge D; Ohman EM; Neely B; Neely M; Goodman SG; Huber K; Chan MY; Cornel JH; Brown E; Zhou C; Jakubowski JA; White HD; Fox KA; Prabhakaran D; Armstrong PW; Tantry US; Roe MT;
    JAMA; 2012 Nov; 308(17):1785-94. PubMed ID: 23117779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.
    Matetzky S; Shenkman B; Guetta V; Shechter M; Beinart R; Goldenberg I; Novikov I; Pres H; Savion N; Varon D; Hod H
    Circulation; 2004 Jun; 109(25):3171-5. PubMed ID: 15184279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CLARITY about the use of clopidogrel in patients with acute coronary syndromes and myocardial infarction.
    Doggrell SA
    Expert Opin Pharmacother; 2005 Aug; 6(10):1761-4. PubMed ID: 16086662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups.
    Budaj A; Yusuf S; Mehta SR; Fox KA; Tognoni G; Zhao F; Chrolavicius S; Hunt D; Keltai M; Franzosi MG;
    Circulation; 2002 Sep; 106(13):1622-6. PubMed ID: 12270853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upstream clopidogrel use and the efficacy and safety of early eptifibatide treatment in patients with acute coronary syndrome: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial.
    Wang TY; White JA; Tricoci P; Giugliano RP; Zeymer U; Harrington RA; Montalescot G; James SK; Van de Werf F; Armstrong PW; Braunwald E; Califf RM; Newby LK
    Circulation; 2011 Feb; 123(7):722-30. PubMed ID: 21300952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early ambulance initiation versus in-hospital initiation of high dose clopidogrel in ST-segment elevation myocardial infarction.
    Postma S; Dambrink JH; Ottervanger JP; Gosselink AT; Koopmans PC; ten Berg JM; Suryapranata H; van 't Hof AW
    Thromb Haemost; 2014 Sep; 112(3):606-13. PubMed ID: 24965669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction.
    Harkness JR; Sabatine MS; Braunwald E; Morrow DA; Sloan S; Wiviott SD; Giugliano RP; Antman EM; Cannon CP; Scirica BM
    Am Heart J; 2010 Jan; 159(1):55-62. PubMed ID: 20102867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.